Bionano Genomics (BNGO) Return on Invested Capital (2018 - 2026)

Bionano Genomics (BNGO) has 9 years of Return on Invested Capital data on file, last reported at 0.04% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital rose 2.0% year-over-year to 0.04%; the trailing twelve-month figure through Mar 2026 stood at 0.04% (up 2.0% YoY), and the FY2024 full-year result was 0.27%, up 28.0% from the prior year.
• Return on Invested Capital fell to 0.04% in Q1 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q4 2025 to a low of 0.15% in Q1 2022.
• A 5-year average of 0.09% and a median of 0.09% in 2022 frame the typical range for Return on Invested Capital.
• Across the five-year window, Return on Invested Capital decreased 14 bps in 2022 and advanced 8 bps in 2025, its largest moves.
• Tracing BNGO's Return on Invested Capital over 5 years: stood at 0.09% in 2022, then tumbled by 63 bps to 0.14% in 2023, then soared by 51 bps to 0.07% in 2024, then jumped by 83 bps to 0.01% in 2025, then sank by 208 bps to 0.04% in 2026.
• Business Quant data shows BNGO's Return on Invested Capital at 0.04% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.